Paraganglioma Presenting as a Nasal Septal Mass: Case Report and Literature Review.
1. IntroductionParagangliomas are rare, slow-growing neuroendocrine tumors arising from cells of neural crest origin. They typically originate from the adrenal gland, but occur extraadrenally in 5-10% of cases [1]. In the head and neck region, paragangliomas make up only 0.6% of all tumors, most commonly in the carotid body and jugular-tympanic regions [1-3]. Though rare, there are few reported cases of paragangliomas arising in the nasal cavity and paranasal sinuses [4-8]. To our knowledge, there has only been one previously reported case of a paraganglioma originating from the nasal septum [8].
2. Case Report
A 70-year-old female complaining of persistent nasal congestion and obstruction presented to our clinic for evaluation. She denied any headache or epistaxis. Nasal endoscopy was performed which showed a posterior septal mass approaching the sphenoid sinuses bilaterally and partially obstructing the view of the nasopharynx. The overlying mucosa was intact except for a small area superiorly which showed a soft granulomatous mass protruding into the left nasal cavity.
The patient was taken to the operating room for septoplasty with biopsy of the mass at an outside institution. Microscopic examination of the biopsy specimen demonstrated clusters of epithelioid-appearing cells separated by bands of fibrillary stroma. The epithelioid cells were noted to have abundant amphophilic cytoplasm, uniform, rounded nuclei with "salt and pepper" chromatin, and small nucleoli. No mitotic activity, invasion, necrosis, or calcification was seen. Immunohistochemical staining demonstrated positivity for neuron-specific enolase (NSE), chromogranin A, synaptophysin, and CD56 cell markers within the epithelioid cells. Fibrillary cells were positive for NSE, chromogranin A, S-100, glial fibrillary acid protein (GFAP), and CD56 cell markers. Based on the histological appearance and immunohistochemical staining, a diagnosis of paraganglioma was made.
The patient was referred to our institution for further management. Preoperative CT imaging showed a smoothly marginated, soft tissue density mass centered at the posterior nasal septum with extension into the nasopharynx and bulging into the right sphenoid sinus (Figure 1). Severe thinning and smooth remodeling of the anterior wall of the sphenoid sinus and anterior clivus were seen. MRI imaging demonstrated hyperintense signaling of the mass on T1weighted images with a peripheral rim of hypointense signaling on T2-weighted imaging suggestive of a capsule.
An endoscopic resection of the mass was performed. Intraoperatively, a large mass was seen in the posterior aspect of the septum, bulging into the bilateral nasal cavities and extending into the sphenoid sinuses (Figure 2). Erosion of the bone of the rostrum and anterior face of the sphenoid were also seen. Complete resection of the mass was achieved through a posterior septectomy and bilateral sphenoidotomy with tissue removal. Postoperative histologic analysis of the specimen was consistent with a paraganglioma (Figure 3).
The patient has been symptom free without local recurrence 3 months following tumor resection.
3. Discussion
Paragangliomas arising from the nasal cavity and nasal sinuses are extremely rare. Only 48 total cases of paragangliomas occurring in the nasal cavity or paranasal sinuses have been reported to date, occurring in patients with ages ranging between 8 and 89 years old, with an average age of 49 years old. These tumors are slightly more prevalent amongst females (60.4%). Twelve were reported to be malignant in nature, demonstrating either intracranial extension or metastasis to the cervical lymph nodes, brain, and bone. These masses were most frequently reported to originate from the ethmoid sinuses, middle turbinate, and maxillary sinuses. Other less common locations of origin reported include the superior and inferior turbinates, and the sphenoid and frontal sinuses. To the best of our knowledge, there has only been one other reported case of a paraganglioma originating from the nasal septum (Table 1) [8].
The most commonly reported symptoms included nasal obstruction, headache, and recurrent epistaxis. The vast majority of reported cases were functionally inactive, with no evidence of catecholamine or adrenocorticotropic hormone (ACTH) secretion. However, there have been a few reported cases of metabolically active tumors secreting ACTH and catecholamines, causing hypertension and other cushingoid features in the affected patient [12, 13, 30]. As such, testing for catecholamine and metanephrines is recommended in symptomatic patients [29, 33].
The origin of paragangliomas in the nasal cavity and paranasal sinuses remains unclear. Although paraganglionic tissue has never been demonstrated in the nasal cavity, a wider distribution ofparaganglionic tissue is thought to exist in fetuses and neonates, degenerating after birth [42, 43]. Some authors have suggested that the migration of these embryonic paraganglionic cells accounts for the occurrence of paragangliomas in areas with no known paraganglionic tissue like the nasal cavity [13,29,42,44]. Additionally, it has been shown that paraganglionic tissue exists around the terminal portion of the maxillary artery in infants and could possibly represent a point of origin for paragangliomas in the nasal cavity due to its anatomic proximity [19, 45]. Others have suggested that the paraganglionic tissue may exist in the pterygopalatine fossa due to the close relationship of paraganglionic tissue with arteries and cranial nerves [18, 19, 22].
In contrast, chondrocytes of the cartilaginous septum develop from neural crest cells between the nasal cavities by the ninth week of embryonic development [46, 47]. This is evident by the expression of various neural crest stem cell markers in nasal septum progenitor cells [48]. Several studies have demonstrated that these neural crest-derived chondrocytes in an adult septum retain pluripotent properties, with the capacity for osteogenic, chondrogenic, and neurogenic differentiation [48, 49]. It is possible that the neural crest origin of septal chondrocytes plays an important factor in the development of nasal septal paragangliomas. Despite the neural crest origins of nasal chondrocytes, paragangliomas arising from the nasal septum are extremely rare.
Masses arising from the nasal septum represent a broad spectrum of diagnoses including polyps, chondromas, hematomas, and hemangiomas. Less common septal lesions include sarcomas, melanomas, and other neoplasms [46, 50]. Patients with septal masses typically present with nonspecific symptoms of nasal obstruction or epistaxis, making it difficult to diagnose these masses based on clinical evaluation alone. CT imaging and MR imaging are useful tools in determining exact locations and boundaries of lesions, as well as identifying any erosion or extension into surrounding structures, though imaging features of most masses are nondiagnostic. Diagnosis of such masses requires a combination of clinical history and histopathologic findings. Although paragangliomas of the nasal septum are extremely rare, they should be included in the differential diagnosis when evaluating a septal mass.
The classical histologic appearance of a paraganglioma features an alveolar pattern of well-defined clusters of epithelioid chief cells with round nuclei and eosinophilic cytoplasm. These cells form a "zellballen" pattern of nests separated by vascular stroma and spindle-shaped sustentacular cells [28, 43]. Immunohistochemical staining of paragangliomas generally demonstrates positive markers for NSE, synaptophysin, and chromogranin within the chief cells and S-100 and GFAP within the sustentacular cells [8, 25, 43].
Although the majority of reported nasal paragangliomas are benign, 12 of the cases presented in this review (25.0%) were reported to be malignant, demonstrating intracranial invasion and/or metastasis to the brain, cervical lymph nodes, and bones. It is widely accepted that malignancy cannot be diagnosed by histology alone, but requires evidence of bony invasion or distant metastasis [18, 19, 22]. Certain histological features such as mitotic figures, cellular pleomorphism, necrosis, and vascular invasion can be suggestive of malignancy, though none of these features have been shown to be reliable predictors of malignancy [19, 51]. As such, evaluation with CT imaging and MRI imaging plays a key role in both localization of the primary tumor and identification of local invasion or metastasis.
Almost all of the cases presented in this review were treated surgically. Suggested management of sinonasal paragangliomas involves surgical excision with close followup, as several cases of recurrence have been reported [4, 22, 29]. Due to the rich vascularity of these masses, preoperative embolization of the vessels supplying the tumor has been suggested to reduce bleeding during surgery [4,22,24]. Many authors suggest the use of radiation therapy to slow the rate of recurrence, although radiation therapy alone has not been shown to be curative [3, 22, 33]. Chemotherapy as a primary treatment for these tumors has been shown to be largely ineffective, though 3 cases reported in this review reported the use of chemotherapy in addition to surgery and radiation therapy in the management of malignant sinonasal paragangliomas [4, 22].
4. Conclusion
We present a rare case of a paraganglioma presenting as a septal mass. To the best of the authors' knowledge, only one other case of nasal septal paragangliomas has been reported. Clinically, these lesions cause symptoms of obstruction, congestion, headache, and epistaxis. Recognizing that paragangliomas can arise from the nasal septum is crucial to accurately diagnose these tumors when evaluating septal lesions. A diagnosis of a paragangliomas can be confirmed based on the histopathologic imaging. These tumors are usually benign but require additional imaging as malignancy cannot reliably be ruled out on the basis of histology alone. Treatment of these tumors requires surgical resection, though radiation therapy has been to show slow growth and decrease recurrence.
https://doi.org/10.1155/2018/1413960
Conflicts of Interest
The authors declare that there are no conflicts of interest or financial disclosures.
Acknowledgments
The authors thank Dr. David Yau for providing the histopathology images and Dr. John Go for reviewing the radiology images.
References
[1] C. Offergeld, C. Brase, S. Yaremchuk et al., "Head and neck paragangliomas: clinical and molecular genetic classification," Clinics, vol. 67, no. 1, pp. 19-28, 2012.
[2] J. H. Lee, F. Barich, L. H. Karnell et al., "National Cancer Data Base report on malignant paragangliomas of the head and neck," Cancer, vol. 94, no. 3, pp. 730-737, 2002.
[3] E. E. Lack, A. L. Cubilla, J. M. Woodruff, and H. W. Farr, "Paragangliomas of the head and neck region: a clinical study of 69 patients," Cancer, vol. 39, no. 2, pp. 397-409, 1977.
[4] K. Papaspyrou, H. J. Welkoborsky, H. Gouveris, and W. J. Mann, "Malignant and benign sinonasal paragangliomas," Laryngoscope, vol. 123, no. 8, pp. 1830-1836, 2013.
[5] L. Granato, J. D. Prospero, and D. M. Filho, "Nasal paraganglioma: a case report and literature review," International Archives of Otorhinolaryngology, vol. 17, no. 1, pp. 92-95, 2013.
[6] U. Kisser, T. Braun, D. Mayr, and A. Leunig, "Paraganglioma of the maxillary sinus," Auris Nasus Larynx, vol. 40, no. 5, pp. 506-509, 2013.
[7] H. Morales, M. Castillo, and V. Jewells, "Paraganglioma of the sphenoid sinus: case report and review of literature," Clinical Imaging, vol. 31, no. 1, pp. 32-36, 2007.
[8] R. Srivastava, N. Wadhwa, S. Gupta, and U. Razdan, "Nasal polyp--an incidental paraganglioma," Turkish Journal of Pathology, vol. 32, no. 3, pp. 196-199, 2016.
[9] W. B. Harkins, "Nonchromaffin paraganglioma of the nasal sinuses," Laryngoscope, vol. 67, no. 3, pp. 246-259, 1957.
[10] T. E. Moran, "Nonchromaffin paraganglioma of the nasal cavity," Laryngoscope, vol. 72, no. 2, pp. 201-206, 1962.
[11] D. K. Gosavi and A. T. Mohidekar, "Chemodectoma of the nose and sphenoid sinus," Journal of Laryngology & Otology, vol. 92, no. 9, pp. 813-816, 1978.
[12] D. Apple and K. Kreines, "Cushing's syndrome due to ectopic ACTH production by a nasal paraganglioma," American Journal of the Medical Sciences, vol. 283, no. 1, pp. 32-35, 1982.
[13] L. J. Koegel, H. L. Levine, and S. R. Waldman, "Paraganglioma of the sphenoid sinus appearing as labile hypertension," Otolaryngology-Head and Neck Surgery, vol. 90, no. 6, pp. 704-707, 1982.
[14] M. Z. Himelfarb, N. L. Ostrzega, J. Samuel, and E. Shanon, "Paraganglioma of the nasal cavity," Laryngoscope, vol. 93, no. 3, pp. 350-352, 1983.
[15] H. J. Straehler-Pohl, "Paraganglioma of the nasal cavity," Laryngologie, Rhinologie, Otologie, vol. 64, no. 8, pp. 399-402, 1985.
[16] N. Ueda, A. Yoshida, R. Fukunishi, H. Fujita, and N. Yanagihara, "Nonchromaffin paraganglioma in the nose and paranasal sinuses," Pathology International, vol. 35, no. 2, pp. 489-495, 1985.
[17] D. J. Watson, "Nasal paraganglioma," Journal of Laryngology & Otology, vol. 102, no. 6, pp. 526-529, 1988.
[18] G. H. Branham, D. R. Gnepp, S. O'McMenomey, and W. H. Friedman, "Malignant paraganglioma--a case report and literature review," Otolaryngology-Head and Neck Surgery, vol. 101, no. 1, pp. 99-103, 1989.
[19] J. A. Kuhn and B. L. Aronoff, "Nasal and nasopharyngeal paraganglioma," Journal of Surgical Oncology, vol. 40, no. 1, pp. 38-45, 1989.
[20] M. Shimoda, N. Shibuya, and O. Sato, "Nasal cavity paraganglioma with intracranial extension," Neurologia medicochirurgica, vol. 29, no. 2, pp. 132-136, 1989.
[21] A. R. Talbot, "Paraganglioma of the maxillary sinus," Journal of Laryngology & Otology, vol. 104, no. 3, pp. 248-251, 1990.
[22] Q. A. Nguyen, P. M. Gibbs, and D. H. Rice, "Malignant nasal paraganglioma: a case report and review of the literature," Otolaryngology--Head and Neck Surgery, vol. 113, no. 1, pp. 157-161, 1995.
[23] A. Biswas and R. Pal, "Paraganglioma of nasal gavity," Indian Journal of Otolaryngology and Head & Neck Surgery, vol. 52, no. 1, pp. 63-64, 1999.
[24] H. S. Sharma, M. Madhavan, N. H. Othman, M. Muhamad, and J. M. Abdullah, "Malignant paraganglioma of frontoethmoidal region," Auris Nasus Larynx, vol. 26, no. 4, pp. 487-493, 1999.
[25] H. J. Welkoborsky, J. Gosepath, R. Jacob, W. J. Mann, and R. G. Amedee, "Biologic characteristics of paragangliomas of the nasal cavity and paranasal sinuses," American Journal of Rhinology, vol. 14, no. 6, pp. 419-426, 2000.
[26] M. Scott, D. S. Brooker, and R. I. Davis, "Paraganglioma of the nasal cavity," Ulster Medical Journal, vol. 70, no. 2, pp. 149-151, 2001.
[27] J. B. Lecanu, S. Arkwright, P. H. Halimi, J. Trotoux, and P. Bonfils, "Multifocal malignant paraganglioma of the paranasal sinuses: a case report," Otolaryngology-Head and Neck Surgery, vol. 126, no. 4, pp. 445-447, 2002.
[28] S. Ketabchi, D. Massi, R. Santoro, and A. Franchi, "Paraganglioma of the nasal cavity: a case report," European Archives ofOto-Rhino-Laryngology, vol. 260, no. 6, pp. 336-340, 2003.
[29] D. A. Mouadeb, R. K. Chandra, D. W. Kennedy, and M. Feldman, "Sinonasal paraganglioma: endoscopic resection with a 4-year follow-up," Head and Neck, vol. 25, no. 12, pp. 1077-1081, 2003.
[30] B. Lieberum, C. Jaspers, and R. Munzenmaier, "ACTH-producing paraganglioma of the paranasal sinuses," HNO, vol. 51, no. 4, pp. 328-331, 2003.
[31] I. Askar, M. F. Oktay, and N. Kilinc, "Use of radial forearm free flap with palmaris longus tendon in reconstruction of total maxillectomy with sparing of orbital contents," Journal of Craniofacial Surgery, vol. 14, no. 2, pp. 220-227, 2003.
[32] M. P. Rocha, A. M. Campagnolo, V. S. Macedo, F. B. Scarton, H. P. Rocha, and G. Kuhl, "Nasal paraganglioma: a case report," Brazilian Journal of Otorhinolaryngology, vol. 71, no. 2, pp. 237-240, 2005.
[33] B. D. Liess, J. A. Horst, and R. P. Zitsch III, "Sphenoid sinus paraganglioma: first reported case," American Journal of Otolaryngology, vol. 28, no. 5, pp. 347-349, 2007.
[34] H. R. Jin, O. J. Lee, and Y. Ahn, "Nasal cavity paraganglioma with malignant transformation: a case report," Auris Nasus Larynx, vol. 35, no. 1, pp. 137-139, 2008.
[35] A. J. Fasunla, T. S. Ibekwe, O. A. Afolabi et al., "Sinonasal paraganglioma: a case report," Oral and Maxillofacial Surgery, vol. 12, no. 2, pp. 93-96, 2008.
[36] R. Zainine, S. Sahtout, H. Ouertani, M. Sellami, N. Beltaief, and G. Besbes, "Paraganglioma of the nasal cavity," Journal Medical Tunisie, vol. 90, no. 2, pp. 178-179, 2012.
[37] J. Michel, D. Taieb, M. Jolibert et al., "Sinonasal paraganglioma with long-delayed recurrence and metastases: genetic and imaging findings," Journal of Clinical Endocrinology & Metabolism, vol. 98, no. 11, pp. 4262-4266, 2013.
[38] N. Amiraraghi, M. I. Syed, S. Syed, and A. T. Williams, "Paraganglioma of the skull base presenting as nasal polyps," Laryngoscope, vol. 123, no. 3, pp. 577-580, 2013.
[39] V. Arora, P. Verma, P. P. Singh, N. Wadhwa, and K. Bhatia, "Sinonasal paraganglioma: a case report and review of literature," Clinical Rhinology An International Journal, vol. 7, no. 2, pp. 87-89, 2014.
[40] W. Yamaguchi, D. Asaka, K. Wada, T. Okushi, and N. Otori, "A case of paraganglioma of the paranasal sinus operated by endoscopic sinus surgery," Oto-Rhino-Laryngology Tokyo, vol. 58, no. 4, pp. 18-23, 2015.
[41] S. Aydin, B. Karabulut, K. S. Orhan, I. Kilicaslan, and K. Deger, "A case of sinonasal paraganglioma with a different morphology: nine-year follow-up," Turkish Journal of Ear Nose and Throat, vol. 25, no. 1, pp. 43-45, 2015.
[42] K. C. Ho, G. Meyer, J. Garancis, and J. Hanna, "Chemodectoma involving the cavernous sinus and semilunar ganglion," Human Pathology, vol. 13, no. 10, pp. 942-943, 1982.
[43] P. G. Wasserman and P. Savargaonkar, "Paragangliomas: classification, pathology, and differential diagnosis," Otolaryngologic Clinics of North America, vol. 34, no. 5, pp. 845-862, 2001.
[44] J. M. Sykes and R. H. Ossoff, "Paragangliomas of the head and neck," Otolaryngologic Clinics of North America, vol. 19, no. 4, pp. 755-767, 1986.
[45] I. H. Girgis and S. A. Fahmy, "Nasopharyngeal fibroma: its histo-pathological nature," Journal of Laryngology & Otology, vol. 87, no. 11, pp. 1107-1123, 1973.
[46] M. P. Valencia and M. Castillo, "Congenital and acquired lesions of the nasal septum: a practical guide for differential diagnosis," RadioGraphics, vol. 28, no. 1, pp. 205-223, 2008.
[47] D. Neskey, J. A. Eloy, and R. R. Casiano, "Nasal, septal, and turbinate anatomy and embryology," Otolaryngologic Clinics of North America, vol. 42, no. 2, pp. 193-205, 2009.
[48] A. Shafiee, M. Kabiri, N. Ahmadbeigi et al., "Nasal septum-derived multipotent progenitors: a potent source for stem cell-based regenerative medicine," Stem Cells and Development, vol. 20, no. 12, pp. 2077-2091, 2011.
[49] K. Pelttari, M. Mumme, A. Barbero, and I. Martin, "Nasal chondrocytes as a neural crest-derived cell source for regenerative medicine," Current Opinion in Biotechnology, vol. 47, pp. 1-6, 2017.
[50] G. Yamin, A. Shabaik, and M. Mafee, "Mass of the anterior nasal septum," JAMA Otolaryngology-Head & Neck Surgery, vol. 142, no. 6, pp. 601-602, 2016.
[51] R. I. Linnoila, H. R. Keiser, S. M. Steinberg, and E. E. Lack, "Histopathology of benign versus malignant sympathoadrenal paragangliomas: clinicopathologic study of 120 cases including unusual histologic features," Human Pathology, vol. 21, no. 11, pp. 1168-1180, 1990.
James H. Kim [ID], (1) Nathan Tu, (2) and Bozena Barbara Wrobel (3)
(1) Keck School of Medicine of the University of Southern California, Los Angeles, CA, USA
(2) University of Southern California LAC+USC Medical Center Department of Otolaryngology, Los Angeles, CA, USA
(3) Associate Professor of Clinical Otolaryngology Head and Neck Surgery, Keck School of Medicine, Los Angeles, CA, USA
Correspondence should be addressed to James H. Kim; kim883@usc.edu
Received 7 August 2018; Accepted 19 November 2018; Published 6 December 2018
Academic Editor: Richard T. Miyamoto
Caption: FIGURE 1: Axial CT image showing a soft tissue mass centered at the posterior nasal septum with extension into the nasopharynx.
Caption: FIGURE 2: Intraoperative image of the mass protruding from the posterior septum within the left nasal cavity.
Caption: FIGURE 3: (a) H&E of the septal mass showing a "zellballen" pattern of clusters of epithelioid cells between bands of fibrillary stroma (20x). IHC staining showing positivity for (b) chromogranin A within epithelioid cells (40x), (c) synaptophysin within epithelioid cells (20x), and (d) S-100 within fibrillary cells (20x).
TABLE 1: Review of reported cases of sinonasal paragangliomas.
Case Author Year Sex Age
1 Harkins [9] 1957 F 52
2 Moran [10] 1962 F 89
3 Lack [3] 1976 F 50
4 F 50
5 M 8
6 Gosavi [11] 1978 M 65
7 Apple [12] 1982 F 50
8 Koegel [13] 1982 F 71
9 Himelfarb [14] 1985 M 41
10 Straehler [15] 1985 M 42
11 Ueda [16] 1985 F 31
12 Watson [17] 1988 M 56
13 Branham [18] 1989 F 25
14 Kuhn [19] 1989 M 62
15 Shimoda [20] 1989 M 58
16 Talbot [21] 1990 F 17
17 Nguyen [22] 1995 F 32
18 Biswas [23] 1999 F 45
19 Sharma [24] 1999 M 33
20 Welkoborsky [25] 2000 F 54
21 F 56
22 M 57
23 Scott [26] 2001 M 24
24 Lecuna [27] 2002 F 72
25 Ketabchi [28] 2003 F 72
26 Mouadeb [29] 2003 M 72
27 Lieberum [30] 2003 M 64
28 Askar [31] 2003 M 47
29 Rocha [32] 2005 M 45
30 Liess [33] 2007 F 64
31 Morales [7] 2007 F 41
32 Jin [34] 2008 F 23
33 Fasunla [35] 2008 F 39
34 Kisser [6] 2012 F 36
35 Zainine [36] 2012 F 43
36 Papaspyrou [4] 2013 F 33
37 M 64
38 F 56
39 F 80
40 M 57
41 F 54
42 Granato [5] 2013 F 61
43 Michel [37] 2013 M 47
44 Amiraraghi [38] 2013 M 29
45 Arora [39] 2014 F 40
46 Yamaguchi [40] 2015 F 66
47 Aydin [41] 2015 F 32
48 Srivastava [8] 2016 M 60
Case Location Biological behavior
1 Ethmoid sinus Benign
2 Nasal cavity Benign
3 High nasal vault Benign (local
recurrence x3)
4 Middle turbinate Benign
5 Middle turbinate Benign
6 Middle turbinate Benign
7 Ethmoid, sphenoid, Benign; ectopic
and maxillary sinuses ACTH production
8 Maxillary and Malignant (extension
sphenoid sinuses into temporal lobe);
catecholamine secretion
9 Middle turbinate Benign
10 Maxillary sinus Benign
11 Maxillary and Benign
ethmoid sinuses
12 Inferior turbinate Benign
13 Maxillary and Malignant
ethmoid sinuses (brain metastasis)
14 Superior nasal cavity, Benign
ethmoid sinus
15 Ethmoid sinus and Malignant (cervical
bilateral frontal fossa lymph nodes metastasis)
16 Maxillary sinus Benign
17 Ethmoid sinus Malignant
(bone metastasis)
18 Middle turbinate Benign
19 Frontal sinus (primary); Malignant
orbit, optic nerve, (recurrence,
cavernous sinus, intracranial
maxillary and ethmoid invasion)
sinuses (recurrent)
20 Nasal cavity Benign
21 Ethmoid sinus Malignant
(brain metastasis)
22 Ethmoid sinus Benign
23 Nasal cavity, Benign
ethmoid sinus
24 Ethmoid sinus (primary); Malignant (recurrence,
maxillary sinus (recurrent) submandibular lymph
nodes metastasis)
25 Nasal cavity Benign
26 Ethmoid sinus Benign
27 Frontal and Benign; ectopic
ethmoid sinuses ACTH production
28 Middle turbinate Benign
29 Nasal cavity Benign
30 Sphenoid sinus, sella, Benign
cavernous sinus
31 Sphenoid and Benign
ethmoid sinuses
32 Superior turbinate Malignant (questionable
transformation
simulating Ewing's
sarcoma/primitive
neuroectodermal tumor)
33 Lateral nasal wall Benign
34 Maxillary sinus Benign
35 Middle turbinate Benign
36 Nasal cavity Benign
37 Ethmoid sinuses, anterior Malignant (recurrent,
skull base, frontal lobe intradural metastases)
dura (primary); ethmoid,
sphenoid, cavernous
sinus, orbit (recurrent)
38 Ethmoid sinus Malignant
(brain metastasis)
39 Nasal cavity, Malignant (recurrent,
maxilloethmoidal angle, intracranial invasion)
maxillary, ethmoid, and
sphenoid sinuses
(primary); nasal cavity,
anterior skull base,
frontal lobe (recurrent)
40 Ethmoid sinus Benign
41 Nasal cavity Benign
42 Nasal cavity Benign
43 Maxillary sinus Malignant (cervical
lymph node metastasis)
44 Cribriform plate and Benign
fovea ethmoidalis
presenting as nasal polyps
45 Lateral nasal wall Benign
46 Ethmoid sinus Benign
47 Nasal cavity, ethmoid sinus Benign (local
recurrence x2)
48 Anterior nasal septum Benign
Case Therapy Follow-up
1 Exc, RT, lig ECA NED at 1 year
2 Exc, ligation of NED at 2 years
external carotid
artery
3 Exc, ligation of NED at 11 years
external carotid following
artery final exc
4 Exc No f/u
5 Exc NED at 7 years
6 Exc, RT NED at 2 years
(incomplete cycle)
7 Exc, RT, hormonal NED at 6 years
pharmacotherapy
8 RT No follow-up
available
9 Exc NED at 1 year
10 Exc No follow-up
available
11 Exc NED at 2.5 years
12 Exc, RT NED at 3 years
13 Exc, RT, CT DOD at 3 years
14 Exc NED at 1 year
15 Exc, RT NED at 2 years
16 Embolization of NED at 3 months
internal maxillary
artery, exc
17 Exc, RT DOD at 15 years
18 Exc NED at 1 month
19 CT, RT, exc; DOD at 19 months
vessel
embolization, exc
8 months later
for recurrence
20 Exc NED at 3 years
21 Exc, RT DOD at 28 months
22 Exc, RT NED at 2 years
23 Exc NED at 15 months
24 Exc No follow-up
available
25 Exc NED at 8 months
26 Exc NED at 4 years
27 Exc NED at 2 years
28 Exc NED at 2 years
29 Exc NED at 5 months
30 Partial exc, RT Residual tumor
stable at 2 years
31 No information No follow-up
available available
32 Exc NED at 3 years
33 Exc NED at 1 year
34 Exc NED at 1 year
35 Exc NED at 2 years
36 Exc NED at 15 years
37 2 exc, RT, CT DOD at 60 months
38 Exc, RT DOD at 28 months
39 Exc DNOD 17 months
after 2nd surgery
40 Exc NED at 2 years
41 Exc NED at 3 years
42 Exc NED at 2 years
43 Exc, RT NED at 1 year
44 Exc NED at 3 years
45 Exc NED at 2 years
46 Exc NED at 1 year
47 Exc NED 5 years
after final exc
48 Exc NED at 18 months
RT, radiation therapy; CT, chemotherapy; Exc, surgical
excision; NED, no evidence of disease; DOD, died of disease.
 Printer friendly
 Cite/link
 Email
 Feedback
| |
| Title Annotation: | Case Report |
|---|---|
| Author: | Kim, James H.; Tu, Nathan; Wrobel, Bozena Barbara |
| Publication: | Case Reports in Otolaryngology |
| Article Type: | Report |
| Date: | Jan 1, 2018 |
| Words: | 4145 |
| Previous Article: | Skull Base Osteomyelitis from Otitis Media Presenting as the Collet-Sicard Syndrome. |
| Next Article: | Concomitant Extramedullary Plasmacytoma in the Oropharynx and Hypopharyngeal Squamous Cell Carcinoma. |
| Topics: | |